Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy
Condition:   Prostate Cancer Interventions:   Other: Focus group creation;   Other: Workshop Sponsor:   Centre Hospitalier Universitaire de Nīmes Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
Conditions:   Breast Cancer Female;   Hormone Receptor Positive Malignant Neoplasm of Breast Interventions:   Drug: Palbociclib;   Drug: Endocrine therapy Sponsors:   Kyoto Breast Cancer Research Network;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2019 Category: Research Source Type: clinical trials